Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 45 articles: HTML format

Single Articles

October 2025
1. CHON YE, Lee J, Yoon EL, Kim SS, et al
   Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study.
   Eur J Gastroenterol Hepatol. 2025;37:1166-1172.
   PubMed     Abstract available
   
   
   September 2025
2. HUANG X, Wang H, Hu J, Cai M, et al
   Development of a retinal vascular nomogram for predicting hepatitis B virus-related cirrhosis: insights into extrahepatic microcirculatory dysfunctions.
   Eur J Gastroenterol Hepatol. 2025 Sep 17. doi: 10.1097/MEG.0000000000003078.
   PubMed     Abstract available
   
   
   
3. WANG Y, Wang H, Wei S, Gao Z, et al
   Metabolomic comparative study in patients with liver cirrhosis and hepatocellular carcinoma related to hepatitis B virus infection.
   Eur J Gastroenterol Hepatol. 2025;37:1040-1048.
   PubMed     Abstract available
   
   
   August 2025
4. DU M, Li H, Li T, Yi O, et al
   Enhancing diagnostic accuracy for HBV-related cirrhosis progression: predictive modeling using combined Golgi protein 73 and alpha1-microglobulin for the transition from nondecompensated to decompensated cirrhosis.
   Eur J Gastroenterol Hepatol. 2025;37:961-969.
   PubMed     Abstract available
   
   
   July 2025
5. YANG P, Huang W, Xu Y, Li Q, et al
   Global, regional, and national burden of liver cancer due to hepatitis B, 1990-2021 and projections to 2051: a systematic analysis of the Global Burden of Disease Study 2021.
   Eur J Gastroenterol Hepatol. 2025 Jul 31. doi: 10.1097/MEG.0000000000003053.
   PubMed     Abstract available
   
   
   
6. WANG Y, Wang H, Wei S, Gao Z, et al
   Metabolomic comparative study in patients with liver cirrhosis and hepatocellular carcinoma related to hepatitis B virus infection.
   Eur J Gastroenterol Hepatol. 2025 Jul 22. doi: 10.1097/MEG.0000000000003021.
   PubMed     Abstract available
   
   
   June 2025
7. HAGE K, Koole J, Boyd A, Matser A, et al
   Incidence of hepatitis C virus infection and associated determinants among men who have sex with men without HIV in Amsterdam, the Netherlands, between 2012 and 2021.
   Eur J Gastroenterol Hepatol. 2025 Jun 23. doi: 10.1097/MEG.0000000000003008.
   PubMed     Abstract available
   
   
   May 2025
8. PAKUWAL E, Tan JL, Page AJ, Stringer AM, et al
   A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis.
   Eur J Gastroenterol Hepatol. 2025 May 8. doi: 10.1097/MEG.0000000000003003.
   PubMed     Abstract available
   
   
   
9. HABIBI MA, Aghayee F, Mirjani MS, Karimifar MR, et al
   The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review and quality assessment.
   Eur J Gastroenterol Hepatol. 2025 May 6. doi: 10.1097/MEG.0000000000002981.
   PubMed     Abstract available
   
   
   
10. CHEN J, Liu X, Guan C, Peng Y, et al
    Sterile systemic inflammation reaction associated with 90-day mortality in patients with HBV-related acute-on-chronic liver failure.
    Eur J Gastroenterol Hepatol. 2025;37:644-651.
    PubMed     Abstract available
    
    
    March 2025
11. GARCIA-HEROLA A, Sanchez-Reyes MS, Gomez-Escolar L, Llobregat L, et al
    Efficiency of opportunistic population screening in a gastrointestinal endoscopy unit as a hepatitis C elimination strategy.
    Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002973.
    PubMed     Abstract available
    
    
    
12. HU Y, Liu M, Li S, Ji Y, et al
    Co-occurrence of autoimmune liver disease and gallstones: a clinically overlooked phenomenon.
    Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002978.
    PubMed     Abstract available
    
    
    
13. LIU T, Gu J
    A cross-sectional study investigating knowledge, attitudes, and practices of the general population regarding early diagnosis and treatment of hepatitis.
    Eur J Gastroenterol Hepatol. 2025 Mar 4. doi: 10.1097/MEG.0000000000002957.
    PubMed     Abstract available
    
    
    February 2025
14. HE Q, Chen Z, Deng Y, Mao C, et al
    Plasma microRNA-30a expression in patients with chronic hepatitis B and its application value in the assessment of the severity of liver fibrosis.
    Eur J Gastroenterol Hepatol. 2025 Feb 18. doi: 10.1097/MEG.0000000000002918.
    PubMed     Abstract available
    
    
    
15. LIU T, Shi Y, Wu J, Qin L, et al
    Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients.
    Eur J Gastroenterol Hepatol. 2025 Feb 11. doi: 10.1097/MEG.0000000000002946.
    PubMed     Abstract available
    
    
    
16. DOS SANTOS DM, Penteado JO, Nader MM, Basso RP, et al
    Analysis of noninvasive methods in chronic hepatitis/human immunodeficiency virus mono- and co-infected patients with advanced fibrosis.
    Eur J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1097/MEG.0000000000002936.
    PubMed     Abstract available
    
    
    January 2025
17. EL-KASSAS M, Barakat EMF, Shousha HI, Kohla M, et al
    Characteristics and survival of patients with viral versus nonviral associated hepatocellular carcinoma: a multicenter cohort study.
    Eur J Gastroenterol Hepatol. 2025;37:83-93.
    PubMed     Abstract available
    
    
    
18. ALHALABI MM, Almokdad R
    The incidence of hepatitis B reactivation in patients receiving ustekinumab: a systematic review and proportional meta-analysis.
    Eur J Gastroenterol Hepatol. 2025;37:1-9.
    PubMed     Abstract available
    
    
    December 2024
19. 
    The Primary Cause of Markedly Elevated Aminotransferases in Hospitalized Patients with Cirrhosis in Ischemic Hepatitis: Erratum.
    Eur J Gastroenterol Hepatol. 2024;36:1472.
    PubMed    
    
    
    November 2024
20. ZHANG J, Lin Y, Zhu Y
    Recompensation features and prognosis in hepatitis B virus-related acute-on-chronic liver failure patients.
    Eur J Gastroenterol Hepatol. 2024 Nov 14. doi: 10.1097/MEG.0000000000002891.
    PubMed     Abstract available
    
    
    
21. ZHANG S, Zhou T, Wu M, Xiong X, et al
    Sarcopenia is associated with new-onset acute biliary infection within 1 year in patients with hepatitis B virus-related decompensated cirrhosis.
    Eur J Gastroenterol Hepatol. 2024 Nov 8. doi: 10.1097/MEG.0000000000002875.
    PubMed     Abstract available
    
    
    
22. ALLAM J, Ibrahim A, Rockey DC
    The primary cause of markedly elevated aminotransferases in hospitalized patients with cirrhosis in ischemic hepatitis.
    Eur J Gastroenterol Hepatol. 2024;36:1346-1351.
    PubMed     Abstract available
    
    
    October 2024
23. GIORGIO M, Ramirez Ladino KA, Lopez G, Sosa Rojas M, et al
    Frequency of hepatitis D virus with different hepatitis B virus serological markers and coinfections in hospital patients from Argentina: synchronous testing of anti-HDV antibodies and HDV RNA.
    Eur J Gastroenterol Hepatol. 2024 Oct 8. doi: 10.1097/MEG.0000000000002857.
    PubMed     Abstract available
    
    
    September 2024
24. ALLAM J, Ibrahim A, Rockey DC
    The primary cause of markedly elevated aminotransferases in hospitalized patients with cirrhosis in ischemic hepatitis.
    Eur J Gastroenterol Hepatol. 2024 Sep 23. doi: 10.1097/MEG.0000000000002855.
    PubMed     Abstract available
    
    
    July 2024
25. ZHANG Y, Lin X, Wu H, Chen J, et al
    Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation.
    Eur J Gastroenterol Hepatol. 2024 Jul 22. doi: 10.1097/MEG.0000000000002823.
    PubMed     Abstract available
    
    
    
26. DANIELSSON O, Vesterinen T, Arola J, Aberg F, et al
    Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
    Eur J Gastroenterol Hepatol. 2024;36:961-969.
    PubMed     Abstract available
    
    
    June 2024
27. WANG FC, Dong Y, Xu ZQ, Gao YJ, et al
    Characteristics analysis of hepatitis B core-related antigen in children with hepatitis B e antigen-positive chronic viral hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2024 Jun 28. doi: 10.1097/MEG.0000000000002812.
    PubMed     Abstract available
    
    
    
28. LIN CY, Sun WC, Lu CM, Chen WC, et al
    Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation.
    Eur J Gastroenterol Hepatol. 2024 Jun 26. doi: 10.1097/MEG.0000000000002709.
    PubMed     Abstract available
    
    
    
29. XU J, Tan L, Jiang N, Li F, et al
    Assessment of nomogram model for the prediction of esophageal variceal hemorrhage in hepatitis B-induced hepatic cirrhosis.
    Eur J Gastroenterol Hepatol. 2024;36:758-765.
    PubMed     Abstract available
    
    
    
30. CADRANEL JD, Zougmore HT, Efole JN, Hanslik B, et al
    Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France.
    Eur J Gastroenterol Hepatol. 2024;36:735-741.
    PubMed     Abstract available
    
    
    May 2024
31. VUKOVIC MN, Jaksic M, Stojanovic D, Smolovic B, et al
    Time trends in liver cancer mortality rates in Montenegro from 1990 to 2018.
    Eur J Gastroenterol Hepatol. 2024;36:622-627.
    PubMed     Abstract available
    
    
    
32. PEPPAS S, Doumas S, Suvarnakar A, Chou J, et al
    Clinical outcomes with metformin use in diabetic patients with compensated cirrhosis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024;36:674-682.
    PubMed     Abstract available
    
    
    April 2024
33. MACIEL AMA, Ferraz MLCG, Perez RM, Brandao-Mello CE, et al
    Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors.
    Eur J Gastroenterol Hepatol. 2024;36:482-488.
    PubMed     Abstract available
    
    
    
34. ARSLAN E, Yildiz Y, Karasahin O, Demir Y, et al
    Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic?
    Eur J Gastroenterol Hepatol. 2024;36:438-444.
    PubMed     Abstract available
    
    
    
35. KOROGLU M, Ayvaz MA, Bakan SB, Sirin A, et al
    Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?
    Eur J Gastroenterol Hepatol. 2024;36:489-497.
    PubMed     Abstract available
    
    
    March 2024
36. HATOUM S, Rockey DC
    Long-term outcomes of patients with autoimmune hepatitis induced cirrhosis after immunosuppressive treatment.
    Eur J Gastroenterol Hepatol. 2024 Mar 28. doi: 10.1097/MEG.0000000000002714.
    PubMed     Abstract available
    
    
    
37. YUKSEKYAYLA O, Kina N, Ulaba A, Emin Ergun M, et al
    The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study.
    Eur J Gastroenterol Hepatol. 2024 Mar 4. doi: 10.1097/MEG.0000000000002747.
    PubMed     Abstract available
    
    
    
38. LAI X, Chen H, Dong X, Zhou G, et al
    AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection.
    Eur J Gastroenterol Hepatol. 2024;36:338-344.
    PubMed     Abstract available
    
    
    
39. ARYAN M, Qian S, Chen Z, Louissaint J, et al
    Patients with early-stage alcohol-associated liver disease are at increased risk of hospital readmission and death.
    Eur J Gastroenterol Hepatol. 2024;36:318-325.
    PubMed     Abstract available
    
    
    February 2024
40. ABDULLAYEVA M, Celik M, Kuruuzum Z
    The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level.
    Eur J Gastroenterol Hepatol. 2024;36:245-249.
    PubMed     Abstract available
    
    
    January 2024
41. BRUNNER N, Grischott T, Bruggmann P
    Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort.
    Eur J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1097/MEG.0000000000002705.
    PubMed     Abstract available
    
    
    November 2023
42. WANG X, Liu H, Wang P, Wang Y, et al
    A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002661.
    PubMed     Abstract available
    
    
    
43. UZEL A, Ebik B, Bucaktepe GE, Yolacan R, et al
    Do oral antiviral drugs used in the treatment of chronic hepatitis B cause erectile dysfunction?
    Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002672.
    PubMed     Abstract available
    
    
    
44. TSAI PS, Cheng YM, Wang CC, Kao JH, et al
    The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Eur J Gastroenterol Hepatol. 2023;35:1278-1283.
    PubMed     Abstract available
    
    
    October 2023
45. OZDEN I, Kinaci E, Ocak I, Colak M, et al
    Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2023 Oct 6. doi: 10.1097/MEG.0000000000002655.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.